Accès ouvert
2026
article
OpenAlex
Reza Shirkoohi, Sharareh Eskandarieh, Abbas Farahani, Farideh Ghanbari Mardasi et autres
ABSTRACT Gastric cancer often presents at advanced stages, limiting treatment outcomes. Circulating tumor cells (CTCs), particularly those undergoing epithelial–mesenchymal transition (EMT), have emerged as promising biomarkers for real‐time disease monitoring. Using magnetic‐activated cell sorting (MACS), we enriched both epithelial (EpCAM + ) …
ir
(code pays fourni par la source)
2026
article
OpenAlex
Ramesh Omranipour, Bita Eslami, Sadaf Alipour, Newsha Nazarian et autres
ir, us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Mohammadreza Salehi, Nafiseh Shahrbaf, Farhad Shahi, Sadegh Khodavaisy et autres
Background: The incidence of invasive aspergillosis (IA) has significantly increased in recent decades. In patients with hematologic malignancies (HM), IA is associated with higher mortality rates. Objectives: This study aimed to assess the clinical features of IA in patients with HM. Methods: …
ir
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Hanieh Radkhah, Mohsen Esfandbod, Mohammad Amin Khadembashiri, M. R. Eslami et autres
Introduction: Chemotherapeutic agents have the potential to induce neurotoxicity, resulting in a range of symptoms, including mild paresthesia, neuropathic pain, pronounced ataxia, and significant impairment. Taxane-induced neuropathy (TIN) is a prevalent adverse effect and a significant constraint of Taxane-based chemotherapy protocols in …
ir
(code pays fourni par la source)
2024
book-chapter
OpenAlex
Marzieh Mirtajaddini, Mohammad Sahebjam, Mohsen Esfandbod, Farhad Shahi et autres
ir
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Ali Farahat, Amirhossein Emami, Seyed Reza Safaei Nodehi, Kamran Roudini et autres
Objective: We aimed to investigate safety and efficacy of preoperative chemotherapy using EOX regime in patients with locally advanced gastric and GEJ cancer who were admitted at Imam-Khomeini Oncology clinic and Aram clinic. Method: We performed a mix-cohort study in 51 gastric …
ir
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Farhad Shahi, Saba Fekrvand, Fatemeh Fathi, Mohammad Reza Dabiri et autres
Background: Since 2019, Coronavirus has been a highly contagious disease. The COVID-19 outbreak was declared a pandemic by the World Health Organization in March 2020. Variable laboratory findings are reported in COVID-19 patients, among which elevated levels of D-dimer, lactate dehydrogenase, as …
ir
(code pays fourni par la source)
2023
article
OpenAlex
Fatemeh Bazvand, Zahra Mahdizad, Farhad Shahi, Masoud Mirghorbani et autres
ir, us
(code pays fourni par la source)
2022
article
OpenAlex
Delaram Shayeganmehr, Fatemeh Ramezannia, Behrooz Gharib, Azin Rezaeilaal et autres
ir
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Marziyeh Ghalamkari, Farhad Shahi, Samaneh Salarvand, Aahmad khajeh-mehrizi
Multiple myeloma (MM) has been suggested to associate with other solid tumors. Myeloma or its chemotherapy regimens may be a risk factor for developing primary and secondary malignancies. But the coexistence with other tumors is rare. We report an old patient simultaneously …
ir
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Farhad Shahi, Farahnaz Vafaeezadeh, Nafiseh Ansarinejad, Alireza Ahmadi et autres
Docetaxel is a clinically well established antimitotic chemotherapy medication. Labeled docetaxel indications are breast cancer, gastric cancer, head and neck cancer, non–small cell lung cancer, and prostate cancer. This is a Phase IV study to evaluate the safety profile of docetaxel (Alvotere; …
ir
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Farhad Shahi, Mojtaba Gorji, Mehrdad Payandeh, Hamid Rezvani et autres
CRC is the second and third most common cancer in women and men, respectively. The national comprehensive cancer network guidelines recommend oxaliplatin-based chemotherapy as a preferred regimen for patients with advanced or metastatic colon cancer. Oxaliplatin is also used in the off-label …
ir
(code pays fourni par la source)